Zobrazeno 1 - 10
of 739
pro vyhledávání: '"Tehan B"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Pharmacology Research & Perspectives. Aug2015, Vol. 3 Issue 4, pn/a-N.PAG. 26p.
Autor:
Chi G; Nuffield Department of Medicine, Centre of Medicines Discovery, University of Oxford, Oxford, UK.; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Ebenhoch R; Nuffield Department of Medicine, Centre of Medicines Discovery, University of Oxford, Oxford, UK.; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Man H; Nuffield Department of Medicine, Centre of Medicines Discovery, University of Oxford, Oxford, UK.; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Tang H; Physical and Theoretical Chemistry Laboratory, University of Oxford, Oxford, UK., Tremblay LE; Department of Medicine, Nephrology Research Group, Faculty of Medicine, Laval University, Quebec City, QC, Canada., Reggiano G; Department of Biochemistry, University of Washington, Seattle, WA, USA., Qiu X; Physical and Theoretical Chemistry Laboratory, University of Oxford, Oxford, UK., Bohstedt T; Nuffield Department of Medicine, Centre of Medicines Discovery, University of Oxford, Oxford, UK.; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Liko I; OMass Therapeutics, Ltd., Oxford, UK., Almeida FG; OMass Therapeutics, Ltd., Oxford, UK., Garneau AP; Department of Medicine, Nephrology Research Group, Faculty of Medicine, Laval University, Quebec City, QC, Canada.; Cardiometabolic Axis, School of Kinesiology and Physical Activity Sciences, University of Montréal, Montréal, QC, Canada., Wang D; Nuffield Department of Medicine, Centre of Medicines Discovery, University of Oxford, Oxford, UK.; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK., McKinley G; Nuffield Department of Medicine, Centre of Medicines Discovery, University of Oxford, Oxford, UK.; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Moreau CP; Nuffield Department of Medicine, Centre of Medicines Discovery, University of Oxford, Oxford, UK., Bountra KD; OMass Therapeutics, Ltd., Oxford, UK., Abrusci P; Nuffield Department of Medicine, Centre of Medicines Discovery, University of Oxford, Oxford, UK.; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Mukhopadhyay SMM; Nuffield Department of Medicine, Centre of Medicines Discovery, University of Oxford, Oxford, UK.; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Fernandez-Cid A; Nuffield Department of Medicine, Centre of Medicines Discovery, University of Oxford, Oxford, UK.; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Slimani S; Department of Medicine, Nephrology Research Group, Faculty of Medicine, Laval University, Quebec City, QC, Canada., Lavoie JL; Cardiometabolic Axis, School of Kinesiology and Physical Activity Sciences, University of Montréal, Montréal, QC, Canada., Burgess-Brown NA; Nuffield Department of Medicine, Centre of Medicines Discovery, University of Oxford, Oxford, UK.; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Tehan B; OMass Therapeutics, Ltd., Oxford, UK., DiMaio F; Department of Biochemistry, University of Washington, Seattle, WA, USA., Jazayeri A; OMass Therapeutics, Ltd., Oxford, UK., Isenring P; Department of Medicine, Nephrology Research Group, Faculty of Medicine, Laval University, Quebec City, QC, Canada., Robinson CV; Physical and Theoretical Chemistry Laboratory, University of Oxford, Oxford, UK., Dürr KL; Nuffield Department of Medicine, Centre of Medicines Discovery, University of Oxford, Oxford, UK.; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; OMass Therapeutics, Ltd., Oxford, UK.
Publikováno v:
The EMBO journal [EMBO J] 2021 Jul 15; Vol. 40 (14), pp. e107294. Date of Electronic Publication: 2021 May 25.
Autor:
Tehan, B.
Publikováno v:
BMJ: British Medical Journal, 1993 Jan 01. 306(6870), 146-146.
Externí odkaz:
https://www.jstor.org/stable/29718183
Autor:
Oliva, Paola1 (AUTHOR), Pramanik, Asmita1 (AUTHOR), Jung, Young-Hwan1 (AUTHOR) paola.oliva@nih.gov, Lewicki, Sarah A.1 (AUTHOR), Mwendwa, Jamie M.1 (AUTHOR), Park, Jong Hwan1 (AUTHOR), Jacobson, Kenneth A.1 (AUTHOR) kennethj@niddk.nih.gov
Publikováno v:
Cells (2073-4409). Aug2024, Vol. 13 Issue 16, p1366. 14p.
Autor:
Amato, Sarah1 (AUTHOR), Averna, Monica2 (AUTHOR), Farsetti, Elisa1 (AUTHOR), Guidolin, Diego3 (AUTHOR), Pedrazzi, Marco2 (AUTHOR), Gatta, Elena4 (AUTHOR), Candiani, Simona5,6 (AUTHOR), Maura, Guido5 (AUTHOR), Agnati, Luigi Francesco7 (AUTHOR), Cervetto, Chiara1,6,8 (AUTHOR) chiara.cervetto@unige.it, Marcoli, Manuela5,8 (AUTHOR) chiara.cervetto@unige.it
Publikováno v:
International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p8610. 25p.
Publikováno v:
Journal of Applied Physics; Mar1970, Vol. 41 Issue 3, p1274-1276, 3p
Autor:
Weng Y; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, 200241, China., Yang X; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, 200241, China., Zhang Q; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, 200241, China. qszhang@bio.ecnu.edu.cn., Chen Y; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, 200241, China., Xu Y; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, 200241, China., Zhu C; Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, 201203, China., Xie Q; Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, 201203, China., Wang Y; Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, 201203, China., Yang H; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, 200241, China., Liu M; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, 200241, China., Lu W; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, 200241, China. wqlu@bio.ecnu.edu.cn., Song G; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, 200241, China. gjsong@bio.ecnu.edu.cn.
Publikováno v:
Science China. Life sciences [Sci China Life Sci] 2024 May; Vol. 67 (5), pp. 986-995. Date of Electronic Publication: 2024 Jan 31.
Autor:
Cheng RKY; Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK., Fiez-Vandal C; Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK., Schlenker O; Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK., Edman K; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden., Aggeler B; Bio-techne, 614 McKinley Place NE, Minneapolis, Minnesota 55413, USA., Brown DG; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D, 35 Gatehouse Dr, Waltham, Massachusetts 02451, USA., Brown GA; Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK., Cooke RM; Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK., Dumelin CE; X-Chem Inc., 100 Beaver St., Waltham, Massachusetts 02453, USA., Doré AS; Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK., Geschwindner S; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden., Grebner C; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden., Hermansson NO; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden., Jazayeri A; Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK., Johansson P; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden., Leong L; Bio-techne, 614 McKinley Place NE, Minneapolis, Minnesota 55413, USA., Prihandoko R; Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK., Rappas M; Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK., Soutter H; X-Chem Inc., 100 Beaver St., Waltham, Massachusetts 02453, USA., Snijder A; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden., Sundström L; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden., Tehan B; Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK., Thornton P; Neuroscience, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Granta Park, Cambridge CB21 6GH, UK., Troast D; X-Chem Inc., 100 Beaver St., Waltham, Massachusetts 02453, USA., Wiggin G; Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK., Zhukov A; Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK., Marshall FH; Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK., Dekker N; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden.
Publikováno v:
Nature [Nature] 2017 May 04; Vol. 545 (7652), pp. 112-115. Date of Electronic Publication: 2017 Apr 26.
Autor:
Worzakowska, Marta1 (AUTHOR) marta.worzakowska@mail.umcs.pl, Sztanke, Krzysztof2 (AUTHOR) krzysztof.sztanke@umlub.pl, Sztanke, Małgorzata3 (AUTHOR) malgorzata.sztanke@umlub.pl
Publikováno v:
International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 2, p813. 17p.